MedTrace Logo

Jewel Electrophysiology (EP) Lab Study

NCT05490459 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2026-04-27

Study results available
· View outcomes & findings →

Summary

Single arm open label evaluation of the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) defibrillation waveform in adult cardiac patients.

Conditions

  • Sudden Cardiac Arrest

Interventions

DEVICE

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)

Automatic external cardioverter defibrillator that monitors patients at risk for SCA and provides a therapeutic shock if needed.

Sponsors & Collaborators

  • Element Science, Inc.

    lead INDUSTRY

Principal Investigators

  • Prof. Petr Neužil, MD, PhD, FESC · Nemocnice na Homolce Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-27
Primary Completion
2021-10-07
Completion
2024-04-17

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05490459 on ClinicalTrials.gov